Description neutropenia, febrile neutropenia in patients receiving intensive myelosuppressive cytotoxic chemotherapy for malignant diseases (except for chronic myeloleukosis and myelodysplastic syndrome), as well as neutropenia and its clinical consequences in patients receiving myeloablative therapy followed by allogenic or autologous bone marrow transplantation; mobilization of peripheral blood stem cells, including after myelosuppressive therapy. severe congenital, recurrent or idiopathic neutropenia (absolute neutrophil count less than or equal to 0.5-109/l) in children and adults with a history of severe or recurrent infections; persistent neutropenia (absolute neutrophil count less than or equal to 1.0-109/l) in patients with advanced HIV infection to reduce the risk of bacterial infections when other treatments are not available.
Oncological diseases
.
Active ingredient
Active ingredient
How to take, the dosage
How to take, the dosage
Interaction
Interaction
Special Instructions
Special Instructions
Synopsis
Synopsis
Contraindications
Contraindications
Side effects
Side effects
Overdose
Overdose
Pregnancy use
Pregnancy use
Additional information
Weight | 0.020 kg |
---|---|
Shelf life | 2 years. Do not use after the expiration date stated on the package. |
Conditions of storage | At a temperature of 2-8 °C. . |
Manufacturer | Amgen Europe B.V., Netherlands |
Medication form | solution for injection |
Brand | Amgen Europe B.V. |
Related products
Buy Neupogen syringe-tubes, units 0.5 ml with delivery to USA, UK, Europe and over 120 other countries.